User:Mr. Ibrahem/Mitoxantrone

Mitoxantrone, also known as mitozantrone, is a medication used to treat cancer and multiple sclerosis. Types of cancer it is used for include acute myeloid leukemia, prostate cancer, breast cancer, and non-Hodgkin's lymphoma. It is given by gradual injection into a vein.

Common side effects include nausea, diarrhea, hair loss, infection, fever, swelling, and shortness of breath. Other side effects may include tumor lysis syndrome, neuropathy, bone marrow suppression, and heart damage. Use in pregnancy may harm the baby. It is an anthracenedione antineoplastic agent.

Mitoxantrone was approved for medical use in the United States in 1987. It is available as a generic medication. In the United Kingdom it costs the NHS about £51 per 20 mg vial as of 2021. This amount in the United States costs about 180 USD.